These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32622869)

  • 1. Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).
    Carrascosa JM; Pastor-Nieto MA; Ruiz-González I; Silvestre JF; Borrego L; Gatica-Ortega ME; Giménez-Arnau AM; ;
    Actas Dermosifiliogr (Engl Ed); 2020 Oct; 111(8):650-654. PubMed ID: 32622869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teledermatology for acne patients: How to reduce face-to-face visits during COVID-19 pandemic.
    Villani A; Annunziata MC; Abategiovanni L; Fabbrocini G
    J Cosmet Dermatol; 2020 Aug; 19(8):1828. PubMed ID: 32490578
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 Pandemic and Telephone Triage before Attending Medical Office: Problem or Opportunity?
    Cervino G; Oteri G
    Medicina (Kaunas); 2020 May; 56(5):. PubMed ID: 32443828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patch Testing Interrupted: Virtual Patch Test Readings During the COVID-19 Pandemic.
    Cheng HS
    Dermatitis; 2020; 31(4):e35-e36. PubMed ID: 32665516
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 and the Skin.
    Catalá Gonzalo A; Galván Casas C
    Actas Dermosifiliogr (Engl Ed); 2020; 111(6):447-449. PubMed ID: 32401723
    [No Abstract]   [Full Text] [Related]  

  • 6. The Spanish standard patch test series: 2016 update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).
    Hervella-Garcés M; García-Gavín J; Silvestre-Salvador JF;
    Actas Dermosifiliogr; 2016 Sep; 107(7):559-66. PubMed ID: 27262363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telemedicine for inpatient dermatology consultations in response to the COVID-19 pandemic.
    Trinidad J; Kroshinsky D; Kaffenberger BH; Rojek NW
    J Am Acad Dermatol; 2020 Jul; 83(1):e69-e71. PubMed ID: 32339708
    [No Abstract]   [Full Text] [Related]  

  • 8. Expansion of asynchronous teledermatology during the COVID-19 pandemic.
    Su MY; Das S
    J Am Acad Dermatol; 2020 Dec; 83(6):e471-e472. PubMed ID: 32822793
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Telemedicine Approach to Covid-19 Assessment and Triage.
    Reiss AB; De Leon J; Dapkins IP; Shahin G; Peltier MR; Goldberg ER
    Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32927589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency management of 2019 novel coronavirus: implications for the dermatology department.
    Tao J; Song Z; Yang L; Huang C; Feng A; Man X
    Br J Dermatol; 2020 Jun; 182(6):e195. PubMed ID: 32745237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of patients with lymphatic diseases and lipoedema during the COVID-19 pandemic. Recommendations of the Spanish Group of Lymphology].
    Forner Cordero I; López Martin M; Reina Gutiérrez L; Belmonte R; Ruiz Miñarro R; Crespo Cobo MP; Pardo Sievers B; Pujol Blaya V; De Miguel Benadiba C; Puigdellivol C
    Rehabilitacion (Madr); 2020; 54(4):276-283. PubMed ID: 32863012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department.
    Tao J; Song Z; Yang L; Huang C; Feng A; Man X
    Br J Dermatol; 2020 Jun; 182(6):1477-1478. PubMed ID: 32141058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Translated article] Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).
    Navarro-Triviño FJ; Borrego L; Silvestre-Salvador JF; Mercader-García P; Giménez-Arnau AM; Ortiz-de Frutos FJ; Sanz-Sánchez T; Melé-Ninot G; Sánchez-Gilo A; Zaragoza-Ninet V; Serra-Baldrich E; Miquel-Miquel J; Córdoba-Guijarro S; Rodríguez-Serna M; Ruíz-González I; Carrascosa-Carrillo JM; Gómez-de la Fuente E; Pastor-Nieto MA; Heras-Mendaza F; González-Pérez R; Sánchez-Pedreño Guillén P; Sánchez-Pérez J; Gatica-Ortega ME; Fernández-Redondo V; Hervella-Garcés M; Manrique-Martínez P; Guimaraens-Juanena D; García-Gavín J; Giménez-Arnau E; Figueras-Nart I; Curto-Barredo L; Armario-Hita JC
    Actas Dermosifiliogr; 2024; 115(7):T712-T721. PubMed ID: 38823769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations of the Spanish Association of Neurogastroenterology and Motility (ASENEM) to restart the activity of gastrintestinal motility laboratories after the state of alarm called due to the Covid-19 pandemic.
    Alcedo J; Serra J; Pérez de la Serna J; Mas P; Barba E; Suárez JF; Accarino A;
    Gastroenterol Hepatol; 2020 Oct; 43(8):485-496. PubMed ID: 32680731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
    Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK; Hotte SJ; Meyers BM; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C
    Oncologist; 2020 Jun; 25(6):e936-e945. PubMed ID: 32243668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guiding principles for prioritization of limited in-person dermatology appointments during the COVID-19 pandemic.
    Stoff BK; Blalock TW; Swerlick RA; MacKelfresh JB; Lawley LP; Chen SC
    J Am Acad Dermatol; 2020 Oct; 83(4):1228-1230. PubMed ID: 32682028
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectively engaging geriatric patients via teledermatology.
    Simpson CL; Kovarik CL
    J Am Acad Dermatol; 2020 Dec; 83(6):e417-e418. PubMed ID: 32497703
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.